Pharmaceutical / Drug Definition :
Interferes with histamine effects at histamine1-receptor sites; prevents but doesn't reverse histamine-mediated response. Also possesses CNS depressant and anticholinergic properties.
FDA Label Requirements and Exceptions
FDA Import Information
Dipyridamole (Dipyridamole Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Dipyridamole (Dipyridamole Suppliers)
- Processors Dipyridamole
- Repackers Dipyridamole
- Relabelers Dipyridamole
- Exporters Dipyridamole
- Importers Dipyridamole
For more information about Dipyridamole, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.